PreludeDx™ to Present New DCISionRT® Comparative Data in
Data to Address Limitations in the Applications of Clinicopathologic Factors ...
Stay updated with breaking news from Decision Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data to Address Limitations in the Applications of Clinicopathologic Factors ...
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...
Results show Black women had significantly higher rates of radiation therapy recommendation compared to White women with similar biosignature scores
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it...